...eligible for $374 million in milestones, plus tiered royalties. The companies will use the biotech's Cue Biologics...

...for up to $374 million in milestones, plus tiered royalties. The companies will use Cue's Cue Biologics...

...Duke University (Durham, N.C.) granted Grid Therapeutics LLC (Durham, N.C.), formerly Cue Biologics LLC , exclusive rights to IP...
...26, 2016 ). Duke University , Durham, N.C. Grid Therapeutics LLC , Durham, N.C. Business: Cancer Alicia Parker Duke University Grid Therapeutics LLC Complement...

...Duke University granted Grid Therapeutics LLC (Durham, N.C.), formerly Cue Biologics LLC, exclusive rights to IP covering antibodies that...
...The partners did not respond to inquiries regarding financial details in time for publication. Alicia Parker Duke University Grid Therapeutics LLC Complement...

...suppressed tumors in various cell-based and mouse models of cancer. Now, it is spinning out Cue Biologics...
...Companies and Institutions Mentioned Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Cheshire, Conn. Atreca Inc., Redwood City, Calif. Cue Biologics...
...inflammation or autoimmunity Development status Preclinical Patents Patent application filed Company; lead investigator Duke University; Cue Biologics...